Melanoma Induces Endothelial Folate Hydrolase-1 (FOLH1) Expression and Facilitated Internalization of Immunotheragnostic Agent, J591
Ramirez-Fort, M.K, Meier, B, Vissicchio, J.R, Moy, J, Liu, H, Contassot, E, Robinson, B.D, Navarro, V, Kim, S, Leconet, W, Nguyen, D, Nwokedi, E.C, Lange, C.S, Tagawa, S.T, Bander, N.H, French, L.E
Published in International journal of radiation oncology, biology, physics (01.10.2016)
Published in International journal of radiation oncology, biology, physics (01.10.2016)
Get full text
Journal Article
OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin
Piatek, C.I, Tagawa, S.T, Wei-Tsai, D, Hanna, D, Weitz, I.C, O’Connell, C, Rochanda, L, Groshen, S, Liebman, H.A
Published in Thrombosis research (01.04.2016)
Published in Thrombosis research (01.04.2016)
Get full text
Journal Article
2508 Three-arm phase II randomized trial of docetaxel monotherapy or combined with ramucirumab or icrucumab in second-line locally advanced or metastatic urothelial carcinoma
Petrylak, D.P, Tagawa, S.T, Kohli, M, Eisen, A, Canil, C, Sridhar, S.S, Spira, A, Yu, E.Y, Burke, J.M, Shaffer, D, Pan, C.X, Kim, J.J, Aragon-Ching, J.B, Tang, S, Zhang, H, Cavanaugh, C.T, Kauh, J.S, Walgren, R.A, Chi, K.N
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
2563 Screening and baseline analysis of circulating tumor cell (CTC) counts and androgen receptor (AR) localization with clinical characteristics of men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY
Tagawa, S.T, Galletti, G, Antonarakis, E.S, Tasaki, S, Gjyrezi, A, Worroll, D, Portella, L, Kirby, B.J, Stewart, J, Zaher, A, Saad, F, Vanhuyse, M, Suri, S, Lannin, T.B, Gruber, C, Pratt, E, North, S, Eisenberger, M.A, Nanus, D.M, Giannakakou, P
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
KEYNOTE-199 cohorts 4 and 5: Pembrolizumab (pembro) plus enzalutamide (enza) for enza-resistant metastatic castration-resistant prostate cancer (mCRPC)
McDermott, R., Graff, J.N., Antonarakis, E.S., Hoimes, C.J., Tagawa, S.T., Hwang, C., Kilari, D., Tije, A.J.T., Omlin, A., Vaishampayan, U.N., Elliott, A., Wu, H., Kim, J., Schloss, C., De Bono, J.S.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
Elevated markers of hemostasis, fibrinolysis and angiogenesis in patients with advanced prostate cancer decrease following hormonal therapy in responding patients
Arnason, J.E, Akhtar, N.H, Afzal, M.Z, Saran, A, Nanus, D.M, Tagawa, S.T
Published in Thrombosis research (01.04.2012)
Published in Thrombosis research (01.04.2012)
Get full text
Journal Article
OC-15 Hemostatic activation, fibrinolysis and angiogenesis are increased in patients with advanced prostate cancer (PC) and decrease in response to hormonal therapy
Arnason, J.E, Hong, S, Dhillon, G.S, Banerjee, S, Gorynski, E, Levandovsky, M, Petrillo, K, Selzer, J, Nanus, D.M, Tagawa, S.T
Published in Thrombosis research (2010)
Published in Thrombosis research (2010)
Get full text
Journal Article
A Phase 2/3 Study of 177Lu-TLX591 Plus SOC vs. SOC Alone in Patients with Metastatic Castration-Resistant Prostate Cancer (ProstACT GLOBAL)
Sartor, A.O., Tagawa, S.T., Lenzo, N., Cade, D., Agarwal, N., Madhu, D.
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Get full text
Journal Article
1828P ARX517: A next generation anti-PSMA antibody drug conjugate (ADC) demonstrates notable stability and pharmacokinetic (PK) profile in the ARX517 phase I clinical trial (APEX-01)
Tagawa, S.T., Shen, J., Skidmore, L., Nelson, J., Pachynski, R., Zhang, S.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
679P Treatment patterns of metastatic castration-sensitive prostate cancer (mCSPC): A real-world evidence study
Tagawa, S.T., Sandin, R., Sah, J., Mu, Q., Freedland, S.J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
PSMAddition: Phase 3 Trial of [177lu]Lu-PSMA-617 Plus Standard of Care (SoC) vs. Soc Alone in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Kim, H., Tagawa, S.T., Sartor, A.O., Saad, F., Reid, A., Sakharova, O., Feng, F.Y., Fizazi, K., Morris, M.
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Get full text
Journal Article
1804P APEX-01: First-in-human phase I/II study of ARX517 an anti- prostate-specific membrane antigen (PSMA) antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Shen, J., Pachynski, R., Nordquist, L.T., Adra, N., Bilen, M.A., Aggarwal, R., Reichert, Z., Schweizer, M., Iravani, A., Aung, S., Hessel, C., Tagawa, S.T.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
600P Final results of phase I/II trial of fractionated dose 177Lu-PSMA-617 for metastatic castration-resistant prostate cancer (mCRPC)
Tagawa, S.T., Sun, M., Sartor, O., Thomas, C., Molina, A.M., Sternberg, C.N., Nanus, D.M., Osborne, J., Bander, N.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
647TiP PSMAddition: A phase III trial to compare treatment with 177Lu-PSMA-617 plus standard of care (SOC) versus SOC alone in patients with metastatic hormone-sensitive prostate cancer
Tagawa, S.T., Sartor, O., Saad, F., Sakharova, O., de Bono, J., Feng, F., Fizazi, K., Morris, M.J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1643P Impact of PTEN alterations on clinical outcomes in patients (pts) with de novo metastatic prostate cancer (mPC)
Thapa, B., Henderson, N., Tagawa, S.T., Hwang, C., Sokolova, A.O., Bilen, M.A., Coelho Barata, P.M., Nguyen, C.B., Tripathi, A., Ayanambakkam, A., Graham, L.S., Zakharia, Y., Koshkin, V.S., Heath, E., Dorff, T.B., Armstrong, A.J., McKay, R.R., Alva, A.S., Schweizer, M., Kilari, D.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article